Hybrid was selected by Dendreon Corporation and their agency Euro RSCG Life Central to create a 2-minute animation detailing Dendreon’s development of active immunotherapy as a potential
anticancer treatment.
This presentation also discusses the potential that lies in harnessing the power of the body’s own immune response and the significance of using antigen presenting cells as a means of preparing T-cells
for activation.
The animation was presented at ASCO and the sponsoring company distributed the sales brochures and CDs to
healthcare professionals.
